Brian P. McAndrews
Known title: DirectorCIK: 0001193074
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Frontdoor Prepares for Q3 2026 Earnings Release. Frontdoor Inc. has announced it will soon report its third-quarter 2026 results. Recent analyst commentary highlights potential margin expansion and a return to membership growth, suggesting these factors may be more significant than the previous quarter's performance. The stock currently trades with a high beta, indicating higher volatility relative to the broader market.
Transaction History
| NYT | ▲ Buy | Grant | 176 | $0 | 7/23/2026 | View on chart |
| FTDR | ▲ Buy | Grant | 2,836 | $0 | 5/13/2026 | View on chart |
| NYT | ▲ Buy | Grant | 2,277 | $0 | 4/22/2026 | View on chart |
| NYT | ▲ Buy | Grant | 151 | $0 | 4/16/2026 | View on chart |
| NYT | ▲ Buy | Grant | 132 | $0 | 1/16/2026 | View on chart |
| NYT | ▲ Buy | Grant | 164 | $0 | 10/23/2025 | View on chart |
| NYT | ▲ Buy | Grant | 179 | $0 | 7/24/2025 | View on chart |
| FTDR | ▲ Buy | Grant | 3,317 | $0 | 5/14/2025 | View on chart |
| NYT | ▲ Buy | Grant | 3,589 | $0 | 4/30/2025 | View on chart |
| NYT | ▲ Buy | Grant | 179 | $0 | 4/17/2025 | View on chart |
| NYT | ▲ Buy | Grant | 117 | $0 | 1/23/2025 | View on chart |
| NYT | ▲ Buy | Grant | 115 | $0 | 10/24/2024 | View on chart |
| NYT | ▲ Buy | Grant | 115 | $0 | 7/25/2024 | View on chart |
| FTDR | ▲ Buy | Grant | 4,413 | $0 | 5/14/2024 | View on chart |
| NYT | ▲ Buy | Grant | 4,048 | $0 | 4/24/2024 | View on chart |
| NYT | ▲ Buy | Grant | 139 | $0 | 4/18/2024 | View on chart |
| NYT | ▲ Buy | Grant | 102 | $0 | 1/18/2024 | View on chart |
| NYT | ▲ Buy | Grant | 120 | $0 | 10/26/2023 | View on chart |
| NYT | ▲ Buy | Grant | 120 | $0 | 7/27/2023 | View on chart |
| FTDR | ▲ Buy | Grant | 5,188 | $0 | 5/11/2023 | View on chart |
| NYT | ▲ Buy | Grant | 4,472 | $0 | 4/26/2023 | View on chart |
| NYT | ▲ Buy | Grant | 108 | $0 | 4/20/2023 | View on chart |
| NYT | ▲ Buy | Grant | 106 | $0 | 1/19/2023 | View on chart |
| NYT | ▲ Buy | Grant | 121 | $0 | 10/21/2022 | View on chart |
| NYT | ▲ Buy | Grant | 116 | $0 | 7/21/2022 | View on chart |
| FTDR | ▲ Buy | Grant | 5,682 | $0 | 5/11/2022 | View on chart |
| NYT | ▲ Buy | Grant | 3,836 | $0 | 4/27/2022 | View on chart |
| NYT | ▲ Buy | Grant | 73 | $0 | 4/21/2022 | View on chart |
| NYT | ▲ Buy | Grant | 57 | $0 | 1/20/2022 | View on chart |
| NYT | ▲ Buy | Grant | 42 | $0 | 10/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
NYT faces scrutiny over valuation and moat in recent analysis
Recent commentary questions whether The New York Times offers sufficient value compared to other legacy media stocks, noting concerns about its competitive advantage. This skepticism aligns with the stock trading near its 52-week low and below the average analyst target price. The discussion highlights the importance of assessing long-term earnings power in the current market environment.
NYT faces scrutiny over valuation and moat in recent analysis. Recent commentary questions whether The New York Times offers sufficient value compared to other legacy media stocks, noting concerns about its competitive advantage. This skepticism aligns with the stock trading near its 52-week low and below the average analyst target price. The discussion highlights the importance of assessing long-term earnings power in the current market environment.